Autoantibodies against, aromatic L-amino acid decarboxylase in autoimmune polyendocrine syndrome type I

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 1, 1997, Pages 147-150

  Husebye, Eystein S ^a   Gebre Medhin, Gennet ^a   Tuomi, Tiinamaija ^b   Perheentupa, Jaakko ^c   Landin Olsson, Mona ^d   Gustafsson, Jan ^a   Rorsman, Fredrik ^a   Kämpe, Olle ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c UNIVERSITY OF HELSINKI   (Finland)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID DECARBOXYLASE; AUTOANTIBODY; GLUTAMATE DECARBOXYLASE;

ADULT; ARTICLE; CHRONIC ACTIVE HEPATITIS; FEMALE; HUMAN; IMMUNOPRECIPITATION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MULTIPLE ENDOCRINE ADENOMATOSIS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; VITILIGO;

ADULT; ANIMALS; AROMATIC-L-AMINO-ACID DECARBOXYLASES; AUTOANTIBODIES; DIABETES MELLITUS, TYPE 1; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; FINLAND; HUMANS; ISLETS OF LANGERHANS; MALE; POLYENDOCRINOPATHIES, AUTOIMMUNE; PROTEIN BIOSYNTHESIS; RATS; SWEDEN; TRANSCRIPTION, GENETIC;

EID: 0031033052     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.1.147     Document Type: Article

References (21)

1. Neufeld M, Maclaren N, Blizzard R. 1980 Autoimmune polyglandular syndromes. Pediatr Ann. 9:154-162.
2. Ahonen P, Myllärniemi S, Sipilä I, Perheentupa J. 1990 Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med. 322:1829-1836.
3. Aaltonen J, Björses P, Sandkuijl L, Perheentupa J, Peltonen L. 1994 An autosomal locus causing autoimmune disease: autoimmune polyglandular disease type I assigned to chromosome 21. Nat Genet. 8:83-88.
4. Winqvist O, Gustafsson J, Rorsman F, Karlsson FA, Kämpe O. 1993 Two different cytochrome P450 enzymes are the adrenal antigens in autoimmune polyendocrine syndrome type I and Addison's disease. J Clin Invest. 92:2377-2385.
5. Uibo R, Aavik E, Peterson P, et al. 1994 Autoantibodies to cytochrome P450 enzymes P450scc, P450c17, and P450c21 in autoimmune polyglandular disease types I and II and in isolated Addison's disease. J Clin Endocrinol Metab. 78:323-328.
6. Winqvist O, Karlsson FA, Kämpe O. 1992 21-hydroxylase, a major autoantigen in idiopathic Addison's disease. Lancet. 339:1559-1562.
7. Banga JP, McGregor AM. 1991 Enzymes as targets for autoantibodies in human autoimmune disease: relevance to pathogenesis. Autoimmunity. 9:177-182.
8. Tuomi T, Björses P, Falorni A, et al. 1996 Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes mellitus in patients with autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab. 81:1488-1494.
9. Bækkeskov S, Aanstoot H-J, Christgau S, et al. 1990 Identification of the 64K autoantigen in IDDM as the GABA synthesizing enzyme glutamic acid decarboxylase. Nature. 347:151-156.
10. Velloso LA, Winqvist O, Gustafsson J, Kämpe O, Karlsson, FA. 1994 Autoantibodies against a novel 51 kDa islet antigen and glutamate decarboxylase isoforms in autoimmune polyendocrine syndrome type I. Diabetologia. 37:61-69.
11. Björk E, Velloso LA, Kämpe O, Karlsson FA. 1994 GAD autoantibodies in IDDM, stiff-man syndrome, and autoimmune polyendocrine syndrome type I recognize different epitopes. Diabetes. 43:161-165.
12. Rorsman F, Husebye ES, Winqvist O, Björk E, Karlsson FA, Kämpe O. 1995 Aromatic L-amino acid decarboxylase, a pyridoxalphosphate-dependent enzyme, is a β-cell autoantigen. Proc Natl Acad Sci USA. 92:8626-8629.
13. Christenson JG, Dairman W, Udenfriend S. 1972 On the identity of DOPA decarboxylase and 5-hydroxytryptophan decarboxylase. Proc Natl Acad Sci USA. 69:343-347.
14. Rahman MK, Nagatsu T, Kato T. 1981 Aromatic l-amino acid decarboxylase activity in central and peripheral tissues and serum of rats with IDOPA and 15-hydroxytryptophan as substrates. Biochem Pharmacol. 30:645-649.
15. Landin-Olsson M, Karlsson FA, Lernmark A, Sundkvist G. 1992 Islet cell and thyrogastric antibodies in 633 consecutive 15- to 34-yr-old patients in the diabetes incidence study in Sweden. Diabetes. 41:1022-1027.
16. r islet cell antigen expression. Diabetes. 38:1326-1328.
17. Grubin CE, Daniels T, Toivola B, et al. 1994 A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia. 37:344-350.
18. Falorni A, Nikoshkov A, Laureti S, et al. 1995 High diagnostic accuracy for idiopathic Addison's disease with a sensitive radiobinding assay for autoantibodies against recombinant human 21-hydroxylase. J Clin Endocrinol Metab. 80:2752-2755.
19. Døskeland AP, Martinez A, Knappskog PM, Flatmark T. 1996 Phosphorylation of recombinant human phenylalanine hydroxylase: effect on catalytic activity, substrate activation and protection against non-specific cleavage of the fusion protein by restriction protease. Biochem J. 313:409-414.
20. Dominici P, Tancini B, Barra D, Voltattori CB. 1989 Purification and characterization of rat liver 3,4-dihydroxyphenylalanine decarboxylase. Eur J Biochem. 169:209-213.
21. Song Y-H, Conner E, Li Y, Zorovich B, Balducci P, Maclaren N. 1994 The role of tyrosinase in autoimmune vitiligo. Lancet. 344:1049-1052.